TMO
Thermo Fisher Scientific Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$464.37
-11.52 ▼ -2.42%
🌙 3월 13일 7:48 PM ET (한국 3/14 08:48)
$463.50
-0.87 ▼ -0.19%
| Index | S&P 500 | P/E | 26.18 | EPS (ttm) | 17.74 | Insider Own | 0.17% | Shs Outstand | 0.38B | Perf Week | -7.49% |
| Market Cap | 172.51B | Forward P/E | 17.31 | EPS next Y | 9.21% | Insider Trans | -21.04% | Shs Float | 0.37B | Perf Month | -11.91% |
| Enterprise Value | 203.38B | PEG | 1.9 | EPS next Q | 5.25 | Inst Own | 94.47% | Short Float | 0.96% | Perf Quarter | -19.07% |
| Income | 6.70B | P/S | 3.87 | EPS this Y | 7.41% | Inst Trans | 1.44% | Short Ratio | 1.56 | Perf Half Y | -5.5% |
| Sales | 44.56B | P/B | 3.27 | EPS next 5Y | 9.13% | ROA | 6.46% | Short Interest | 3.55M | Perf YTD | -19.86% |
| Book/sh | 141.96 | P/C | 17.06 | EPS past 3/5Y | 0.18% 2.11% | ROE | 13.02% | 52W High | -27.89% ($643.99) | Perf Year | -8.75% |
| Cash/sh | 27.22 | P/FCF | 27.41 | Sales past 3/5Y | -0.27% 6.7% | ROIC | 7.41% | 52W Low | 20.47% ($385.46) | Perf 3Y | -14.25% |
| Dividend Est. | $1.86 (0.4%) | EV/EBITDA | 18.2 | EPS Y/Y TTM | 7.09% | Gross Margin | 40.25% | Volatility(W/M) | 3.16% 2.8% | Perf 5Y | 3.08% |
| Dividend TTM | 1.76 | EV/Sales | 4.56 | Sales Y/Y TTM | 3.91% | Oper. Margin | 18.84% | ATR (14) | 15.13 | Perf 10Y | 231.17% |
| Dividend Ex-Date | 2026/3/13 | Quick Ratio | 1.53 | EPS Q/Q | 9.03% | Profit Margin | 15.05% | RSI (14) | 24.42 | Recom | 1.41 |
| Dividend Gr. 3/5Y | 12.75% 14.34% | Current Ratio | 1.89 | Sales Q/Q | 7.2% | SMA20 | -8.31% ($506.46) | Beta | 0.99 | Target Price | $666.49 |
| Payout | 9.7% | Debt/Eq | 0.76 | Earnings | 1000000 | SMA50 | -16.9% ($558.81) | Rel Volume | 1.33 | Prev Close | $475.89 |
| Employees | 125000 | LT Debt/Eq | 0.69 | EPS/Sales Surpr. | 1.88% 2.22% | SMA200 | -9.51% ($513.17) | Avg Volume(3M) | 2.27M | Price | $464.37 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 51804 | Volume | 3,018,626 | Change | -2.42% |
뉴스 로딩 중...